Surface plasmon resonance imaging protein arrays for analysis of triple protein interactions of HPV, E6, E6AP and p53

被引:31
作者
Ro, HS
Koh, BH
Jung, SO
Park, HK
Shin, YB
Kim, MG
Chung, BH
机构
[1] Korea Res Inst Biosci & Biotechnol, BioNanotechnol Res Ctr, Taejon 305600, South Korea
[2] Gyeongsang Natl Univ, Dept Microbiol, Gyeongnam, South Korea
[3] Gyeongsang Natl Univ, Inst Life Sci, Gyeongnam, South Korea
关键词
human papillomavirus (HPV); protein arrays; protein interaction; surface plasmon resonance imaging;
D O I
10.1002/pmic.200500635
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have developed a surface plasmon resonance (SPR)-based protein microarray to study protein-protein interactions in a high-throughput mode. As a model system, triple protein interactions have been explored with human papillomaviral E6 protein, tumor suppressor p53, and ubiquitin ligase E6AP. Human papillornavirus (HPV) is known to be a causative agent of cervical cancer. Upon infection, the viral E6 protein forms a heterotrimeric protein complex with p53 and E6AP. The formation of the complex eventually results in the degradation of p53. In the present study, a GST-fused E6AP protein was layered onto a glutathione (GSH)-modified gold chip surface. The specific binding of CST-E6AP protein onto the gold chip surface was facilitated through the affinity of GST to its specific ligand GSH. The interacting proteins (E6 and/or p53) were then spotted. Detection of the interaction was performed using a SPR imaging (SPRI) technique. The resulting SPRI intensity data showed that the protein-protein interactions of E6AP, E6, and p53 were detected in a concentration-dependent manner, suggesting that the SPRI-based microarray system can be an effective tool to study protein-protein interactions where multiple proteins are involved.
引用
收藏
页码:2108 / 2111
页数:4
相关论文
共 13 条
[1]   Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53 [J].
Cooper, B ;
Schneider, S ;
Bohl, J ;
Jiang, YH ;
Beaudet, A ;
Vande Pol, S .
VIROLOGY, 2003, 306 (01) :87-99
[2]   Peptide chips for the quantitative evaluation of protein kinase activity [J].
Houseman, BT ;
Huh, JH ;
Kron, SJ ;
Mrksich, M .
NATURE BIOTECHNOLOGY, 2002, 20 (03) :270-274
[3]  
JUNG JM, 2004, ANAL BIOCHEM, V73, P5525
[4]   High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation [J].
Li, XQ ;
Coffino, P .
JOURNAL OF VIROLOGY, 1996, 70 (07) :4509-4516
[5]   Emerging array-based technologies in proteomics [J].
Mirzabekov, A ;
Kolchinsky, A .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (01) :70-75
[6]   A perspective on protein microarrays [J].
Mitchell, P .
NATURE BIOTECHNOLOGY, 2002, 20 (03) :225-229
[7]   Comprehensive identification of human bZIP interactions with coiled-coil arrays [J].
Newman, JRS ;
Keating, AE .
SCIENCE, 2003, 300 (5628) :2097-2101
[8]   Surface plasmon resonance imaging-based protein array chip system for monitoring a hexahistidine-tagged protein during expression and purification [J].
Ro, HS ;
Jung, SO ;
Kho, BH ;
Hong, HP ;
Lee, JS ;
Shin, YB ;
Kim, MG ;
Chung, BH .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2005, 71 (02) :1089-1092
[9]   RECONSTITUTION OF P53-UBIQUITINYLATION REACTIONS FROM PURIFIED COMPONENTS - THE ROLE OF HUMAN UBIQUITIN-CONJUGATING ENZYME UBC4 AND EG-ASSOCIATED PROTEIN (E6AP) [J].
ROLFE, M ;
BEERROMERO, P ;
GLASS, S ;
ECKSTEIN, J ;
BERDO, I ;
THEODORAS, A ;
PAGANO, M ;
DRAETTA, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) :3264-3268
[10]   Ubiquitin, E6-AP, and their role in p53 inactivation [J].
Scheffner, M .
PHARMACOLOGY & THERAPEUTICS, 1998, 78 (03) :129-139